Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Why JD.Com Shares Are Diving

JD.Com Inc (NASDAQ: JD) shares are trading lower by 3.59% to $34.46 Wednesday morning. Shares of large-cap Chinese stocks are trading lower following a drop in China industrial profit in May.
byHenry Khederian
June 28, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

JD.Com Inc (NASDAQ:JD) shares are trading lower by 3.59% to $34.46 Wednesday morning. Shares of large-cap Chinese stocks are trading lower following a drop in China industrial profit in May.

Per a report by Reuters, China’s industrial firms witnessed a continued decline in annual profits, with a 18.8% slump in the first five months. This adds to the previous contraction of 20.6% during January to April.

May’s data meanwhile showed a 12.6% decline in industrial earnings compared to the previous year.

See Also: What’s Going On With Snowflake Stock?

According to Reuters, foreign firms saw a 13.6% decline in earnings from January to May, while private-sector companies experienced a 21.3% slide. The petroleum, coal and fuel processing industry reported the largest slump at 92.8%.

According to data from Benzinga Pro, JD.Com has a 52-week high of $68.29 and a 52-week low of $33.17.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Organigram And This Canadian Cannabis Brand Expand In Europe And Beyond

By Jelena Martinovic
May 28, 10:20 AM
Germany's recent legislative push in the cannabis sector marks a significant turning point not only for the country but also for the European cannabis landscape. Europe has become more open-minded about medical and recreational marijuana over the recent years which is why the growing number of the North American cannabis operators that opted to venture into the new market doesn't come as a surprise. On Tuesday, Toronto-based cannabis giant Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) announced its second international medical cannabis customer in the UK, Avida Medical, a full-service medical cannabis and specials medicines manufacturing business.In the meantime, this week, Canadian cannabis brand Ghost Drops, announced an exclusive partnership with SOMAÍ Group, an international cannabinoid biopharma company with distribution channels.

OGI